West Pharmaceutical Services (WST)
R&D Expense Growth
24.68%
Quarterly · Period ending:
WST R&D Expense Growth
Latest reported24.68%period ending
Latest reported24.68%period ending
WST Quarterly R&D Growth (QoQ) (0.00% → 24.68%)
Latest values, visible window
High-resolution chart · PNG
WST r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 24.6835% | |
| -27.5229% | |
| 27.4854% | |
| -10.4712% | |
| 17.1779% | |
| -11.8919% | |
| 19.3548% | |
| -11.4286% | |
| -0.5682% | |
| -4.3478% | |
| 12.1951% | |
| -0.6061% | |
| -3.5088% | |
| 7.5472% | |
| 16.9118% | |
| -5.5556% | |
| -1.3699% | |
| 6.5693% | |
| 4.5802% | |
| -5.0725% | |
| 13.1148% | |
| -5.4264% | |
| 3.2% | |
| 15.7407% | |
| 0.9346% | |
| 4.902% | |
| 9.6774% | |
| -3.125% | |
| -2.0408% | |
| 0% | |
| -2.9703% | |
| -6.4815% | |
| 12.5% | |
| -1.0309% | |
| 6.5934% | |
| -9% | |
| -2.9126% | |
| 7.2917% | |
| 6.6667% | |
| 2.2727% | |
| -6.383% | |
| -6% | |
| 17.6471% | |
| 4.9383% | |
| 8% | |
| -3.8462% | |
| -18.75% | |
| -3.0303% | |
| -1% | |
| 3.0928% | |
| 1.0417% | |
| 1.0526% | |
| 4.3956% | |
| 5.814% | |
| 4.878% | |
| 0% | |
| -1.2048% | |
| 15.2778% | |
| -6.4935% | |
| 5.4795% | |
| 5.7971% | |
| 0% | |
| 16.9492% | |
| 3.5088% | |
| 5.5556% | |
| -6.8966% | |
| 13.7255% | |
| 8.5106% | |
| 9.3023% | |
| 10.2564% | |
| -15.2174% | |
| -6.1224% | |
| -9.2593% | |
| 17.3913% | |
| 12.1951% | |
| 7.8947% | |
| 5.5556% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |